glp 1 receptor expression Down-regulation of vascular GLP-1 in human subjects with obesity GLP-1R and Diabetes

Diabetes Res Clin Pract 2022;183:109146.ArticlePubMed 80

There is no statistically significant increase in the incidence of pancreatitis compared to placebo, according to extensive meta-analyses of randomized controlled studies (Dankner et al

GLP-1 Injection Site Reactions: Causes and Fixes GLP-1 medications like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) are effective for weight loss, but about 50% of users experience mild injection site reactions

This is what makes them convenient for patients, one injection per week is much more manageable than daily injections, but it also creates the timing questions that do not arise with shorter-acting peptides

Id love to hear your tips in the comments

Communication is text-based through their platform